NDC 69543-253 Virtussin Dac
Codeine Phosphate, Guaifenesin, And Pseudoephedrine Hydrochloride
NDC Product Code 69543-253
NDC Code: 69543-253
Proprietary Name: Virtussin Dac What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name: Codeine Phosphate, Guaifenesin, And Pseudoephedrine Hydrochloride What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Code Structure
Proprietary Name: Virtussin Dac What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name: Codeine Phosphate, Guaifenesin, And Pseudoephedrine Hydrochloride What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Code Structure
- 69543 - Virtus Pharmaceuticals
- 69543-253 - Virtussin Dac
NDC 69543-253-04
Package Description: 118 mL in 1 BOTTLE
NDC 69543-253-16
Package Description: 473 mL in 1 BOTTLE
NDC Product Information
Virtussin Dac with NDC 69543-253 is a a human over the counter drug product labeled by Virtus Pharmaceuticals. The generic name of Virtussin Dac is codeine phosphate, guaifenesin, and pseudoephedrine hydrochloride. The product's dosage form is liquid and is administered via oral form.
Labeler Name: Virtus PharmaceuticalsDosage Form: Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
DEA Schedule: Schedule V (CV) Substances What is the Drug Enforcement Administration (DEA) CV Schedule?
The controlled substances in the CV schedule have an abuse potential and dependence liability less than those listed in CIV and have an accepted medical use in the United States. Substances in schedule CV are often available without prescription, and include preparations containing limited quantities of certain narcotic drugs generally for antitussive and antidiarrheal purposes. Buprenorphine is also a CV schedule drug.
Virtussin Dac Active Ingredient(s)
What is the Active Ingredient(s) List?This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
- CODEINE PHOSPHATE 10 mg/5mL
- GUAIFENESIN 100 mg/5mL
- PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/5mL
- CODEINE PHOSPHATE 10 mg/5mL
- GUAIFENESIN 100 mg/5mL
- PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/5mL
Inactive Ingredient(s)
About the Inactive Ingredient(s)The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.
- ALCOHOL (UNII: 3K9958V90M)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- GLYCERIN (UNII: PDC6A3C0OX)
- POTASSIUM CITRATE (UNII: EE90ONI6FF)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- WATER (UNII: 059QF0KO0R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- SORBITOL (UNII: 506T60A25R)
Administration Route(s)
What are the Administration Route(s)?The translation of the route code submitted by the firm, indicating route of administration.
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
Product Labeler Information
What is the Labeler Name?Name of Company corresponding to the labeler code segment of the Product NDC.
Labeler Name: Virtus Pharmaceuticals
Labeler Code: 69543
FDA Application Number: part341 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 01-31-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.
Labeler Code: 69543
FDA Application Number: part341 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 01-31-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.
* Please review the disclaimer below.
Information for Patients
Codeine
Codeine is pronounced as (koe' deen)
Why is codeine medication prescribed?Guaifenesin
Codeine is used to relieve mild to moderate pain. It is also used, usually in combination with other medications, to reduce coughing. Combination products that contain co...
[Read More]
Guaifenesin is pronounced as (gwye fen' e sin)
Why is guaifenesin medication prescribed?Pseudoephedrine
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a cla...
[Read More]
Pseudoephedrine is pronounced as (soo doe e fed' rin)
Why is pseudoephedrine medication prescribed?
Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseud...
[Read More]
* Please review the disclaimer below.
Virtussin Dac Product Label Images
Virtussin Dac Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Product Labeling Index
- Other
- Otc - Purpose
- Uses
- Otc - Ask Doctor
- Do Not Use
- When Using This Product
- Stop Use And Ask A Doctor If
- Otc - Pregnancy Or Breast Feeding
- Otc - Keep Out Of Reach Of Children
- Directions
- Other Information
- Inactive Ingredients
Other
Drug Facts
Otc - Purpose
Active ingredients (in each 5 mL = 1 tsp)PurposeCodeine phosphate, USP 10 mgCough SuppressantGuaifenesin, USP 100 mgExpectorantPseudoephedrine HCl, USP 30 mgNasal Decongestant
Uses
- Temporarily relieves cough due to minor throat and bronchial irritation as may occur with a coldtemporarily relieves nasal congestion due to the common coldtemporarily restores freer breathing through the nosehelps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productivecalms the cough control center and relieves coughing
Otc - Ask Doctor
- Ask your doctor before use if you haveheart diseasehigh blood pressurethyroid diseasediabetestrouble urinating due to enlarged prostate glandcough that occurs with excessive phlegm (mucus)cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
Do Not Use
- In a child under 2 years of ageif you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.if you or your child has a chronic pulmonary disease or shortness of breathif your child is taking other drugs, unless directed by a doctor
When Using This Product
- Do not use more than directedmay cause drowsinessconstipation may occur or be aggravated
Stop Use And Ask A Doctor If
- You get nervous, dizzy, or have trouble sleepingcough lasts more than 7 days, comes back or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
Otc - Pregnancy Or Breast Feeding
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- Do not exceed 4 doses in any 24 hour period.Attention: A special measuring device should be used to give an accurate dose of this product to children under 6 years of age. Giving a higher dose than recommended by a doctor could result in serious side effects for your child.Adults and children 12 years of age and over:2 tsp (10 mL) every 4 hours, or as directed by a doctor.Children 6 to under 12 years of age:1 tsp (5 mL) every 4 hours, or as directed by a doctor.Children under 6 years of age:Consult a doctor.
Other Information
Each tsp (5 mL) contains 3 mg sodium.Store at controlled room temperature 15°-30°C (59°-86°F).You may report side effects by calling 1-888-848-3593 or FDA at 1-800-FDA-1088.
Inactive Ingredients
Alcohol, caramel flavor, cherry flavor, citric acid, FD&C red #40, glycerin, menthol flavor, potassium citrate, propylene glycol, purified water, sodium benzoate, sodium saccharin, sorbitol 70% solution.
* Please review the disclaimer below.